Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
18.37
-0.48 (-2.55%)
Aug 14, 2025, 2:05 PM - Market open
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of $1.50 billion as of August 14, 2025. Its market cap has increased by 35.94% in one year.
Market Cap
1.50B
Enterprise Value
999.06M
1-Year Change
35.94%
Ranking
Category
Stock Price
$18.37
Market Cap Chart
Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $1.50B, an increase of 4,223.16%. That is a compound annual growth rate of 40.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.54B | 1.37% |
| Dec 31, 2024 | 1.52B | 32.59% |
| Dec 29, 2023 | 1.15B | -2.59% |
| Dec 30, 2022 | 1.18B | 173.74% |
| Dec 31, 2021 | 429.50M | 567.96% |
| Dec 31, 2020 | 64.30M | 320.26% |
| Dec 31, 2019 | 15.30M | -83.62% |
| Dec 31, 2018 | 93.40M | -59.86% |
| Dec 29, 2017 | 232.70M | 6,363.89% |
| Dec 30, 2016 | 3.60M | -55.00% |
| Dec 31, 2015 | 8.00M | -16.67% |
| Dec 31, 2014 | 9.60M | -72.33% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 593.12B |
| Johnson & Johnson | 419.82B |
| AbbVie | 355.78B |
| UnitedHealth Group | 246.24B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.34B |